Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice

Department of Molecular Microbiology and Immunology, St Louis University School of Medicine, 1402 South Grand Avenue, St Louis, MO 63104, USA Correspondence Thomas J. Chambers thomas_chambers2{at}merck.com A molecular clone of Japanese encephalitis virus (JE virus) was derived from the JE virus Naka...

Full description

Saved in:
Bibliographic Details
Published inJournal of general virology Vol. 87; no. 11; pp. 3131 - 3140
Main Authors Chambers, Thomas J, Jiang, Xiaoshan, Droll, Deborah A, Liang, Yan, Wold, William S. M, Nickells, Janice
Format Journal Article
LanguageEnglish
Published Reading Soc General Microbiol 01.11.2006
Society for General Microbiology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Department of Molecular Microbiology and Immunology, St Louis University School of Medicine, 1402 South Grand Avenue, St Louis, MO 63104, USA Correspondence Thomas J. Chambers thomas_chambers2{at}merck.com A molecular clone of Japanese encephalitis virus (JE virus) was derived from the JE virus Nakayama strain and used to produce infectious JE virus in cell culture. The engineered JE virus resembled the parental JE virus in cell-culture properties and was related closely to other JE virus strains based on nucleotide sequence analysis. The JE virus clone was used as a genetic background for construction of a chimeric virus containing the structural proteins prM and E of Dengue virus , serotype 2. The chimeric JE/dengue 2 virus generated authentic dengue 2 structural proteins as assessed by immunoassays for the dengue E protein. It exhibited a small plaque size and less efficient growth in various cell lines than the parental JE virus. JE/dengue 2 virus was non-neuroinvasive for young adult mice, but displayed partial neurovirulence at doses up to 4 log p.f.u. given intracerebrally. Immunization of 3-week-old mice with JE/dengue 2 virus yielded neutralizing-antibody titres against dengue 2 virus and conferred protection against dengue encephalitis caused by neuroadapted dengue 2 virus. A rise in post-challenge neutralizing-antibody titres against dengue 2 virus in surviving mice suggests that immunization is associated with establishment of a memory antibody response in this model. This study demonstrates the capacity of JE virus to serve as a vector for expression of heterologous flavivirus structural proteins. Similar to previous studies with other chimeric flaviviruses, this approach may be useful as a genetic system for engineering experimental vaccines against Dengue virus and other medically important flaviviruses. Published online ahead of print on 27 July 2006 as DOI 10.1099/vir.0.81909-0. Present address: Merck and Co., Inc, PO Box 4, U2D-68, West Point, PA 19486, USA.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1317
1465-2099
DOI:10.1099/vir.0.81909-0